Skip to main content
. Author manuscript; available in PMC: 2010 Jun 14.
Published in final edited form as: Clin Pharmacol Ther. 2009 Nov 4;87(1):100–108. doi: 10.1038/clpt.2009.205

Figure 2.

Figure 2

Mean ± SEM of dose normalized concentration-time profiles of mycophenolic acid (MPA; a), MPA-phenyl glucuronide (MPAG; b) and distribution of MPA to MPAG metabolic ratio (MPAG/MPA AUC0-9h ratio; c) as a function SLCO1B3 T334G genotype in patients co-treated with tacrolimus or sirolimus. In panel c, the lines represent the mean values. *p<0.05; **p<0.005